Pure Biosciences (PURE) Files $50M Mixed Shelf
Tweet
Share
E-mail
Pure Biosciences (Nasdaq: PURE) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $50 million of Preferred Stock, Common Stock, Warrants, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B&R Technology Merger Corp. raises $325M in Nasdaq IPO
- First Choice Healthcare and Westin Acquisition plan $650M SPAC merger
- China Pharma prices $5 million direct offering at $2 per share
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
